The objective of this study is to investigate the feasibility and clinical benefits of the AMDS to treat patients with acute DeBakey type I dissections and/or intramural hematomas (IMH) involving the ascending aorta and aortic arch through open surgical repair.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants with device-related mortality
Timeframe: Early (within 30 days)
Number of participants with device-related mortality
Timeframe: Intermediate (3 months)
Number of participants with device-related mortality
Timeframe: Late (6 months)
Number of participants with neurological complications (TIA, stroke)
Timeframe: Early (within 30 days)
Number of participants with neurological complications (TIA, stroke)
Timeframe: Intermediate (3 months)
Number of participants with neurological complications (TIA, stroke)
Timeframe: Late (6 months)